Related Experiment Videos
Palatal Melanoma: "The Silent Killer".
Georgi Tchernev1,2, Torello Lotti3,4, Uwe Wollina5
1Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria.
Open Access Macedonian Journal of Medical Sciences
|March 14, 2018
Summary
Primary oral melanoma is a rare and aggressive cancer with a poor prognosis. Early detection and accurate diagnosis are crucial for improving survival rates in patients with this uncommon malignancy.
Area of Science:
- Oral oncology
- Dermatopathology
- Surgical oncology
Background:
- Primary melanoma of the oral cavity is a rare malignancy, accounting for approximately 0.2-8.0% of all melanoma cases.
- This cancer exhibits aggressive behavior and a poor prognosis, with a 5-year survival rate ranging from 5-20%.
Observation:
- Initial symptoms of oral melanoma are often subtle and unnoticed, leading to delayed diagnosis.
- A case of palatal melanoma in a 76-year-old female patient is presented.
Findings:
- Late diagnosis significantly worsens the prognosis of oral melanoma.
- There is a lack of standardized classification and therapeutic protocols for oral melanoma due to its rarity.
Implications:
- Emphasizes the critical importance of early detection and accurate diagnosis for improving therapeutic outcomes in oral melanoma.
- Highlights the need for increased awareness among clinicians regarding the signs and symptoms of oral melanoma.
- Underscores the potential for case studies to inform clinical practice and research in rare oral cancers.